Plaintiffs Say CMS’ Frailty Rule Raises Projected Medicaid Losses From 6.4 Million to 8.2 Million a Year
Congress named who is medically frail. CMS’s rule decides who can prove it, and the new lawsuit is about that gap.
Congress named who is medically frail. CMS’s rule decides who can prove it, and the new lawsuit is about that gap.
CMS frames this as fraud recovery. Its release says much less about the 760,000 people whose marketplace coverage ends.
CMS expects much of the coverage loss to come from process, not from failing the test. The insurer asked doctors to help.
Three routes to patients in four days. In a market that pays out of pocket, not one announcement carries a price.
Forty states signed. Reporting last week put it at seven. The list CMS has never published is the manufacturers.
Thirty-six fewer items produced the same saving. Nothing about efficacy changed. The medicines that grew paid for it.
Coverage will call this a mental health guideline. One recommendation reaches into a commercial market and tells its providers to turn business away.
Seven of 19 applicant states have signed. CMS itself tells them to check whether its international price beats the rebates they already have.
An industry association found the public agrees with industry. The news came later, from a division director naming headcount as the bottleneck.
The expansion is the announcement. Payers covering 165 million pledged to align with a model none of their members can join.